The entourage effect is the assumption that the cannabinoids, terpenes and flavonoids of the hemp plant act differently together than each compound does in isolation. So what is an entourage effect in plain terms? It is a hypothesis about plant compounds, traced to a 1998 lab paper and a 2011 review, and it has not been demonstrated as a mechanism. On product labels the phrase still works as a selling point, which is exactly why we test it here rather than repeat it.
We start with what the term means and which compounds it names, then look at the terpene version and at what the studies actually measured. After that come the criticism, what the idea means for full-spectrum, broad-spectrum and isolate, and what a certificate of analysis can confirm about a label.
Note: this article is for information only and is not medical advice. The products sold at uWeed are not medicines; CBD oils are sold as cosmetic or aroma products and are not intended for ingestion.
Entourage Effect: Meaning and Definition
The entourage effect is a hypothesis from cannabinoid research. It proposes that the compounds of the hemp plant — cannabinoids, terpenes and flavonoids — influence one another, so that a whole-plant extract behaves differently from a single isolated compound. It is a proposed explanation, not a confirmed model of how these compounds interact.
The entourage effect meaning comes straight from the French: an “entourage” is a retinue, the escort that travels with a central figure. In the term, the companion compounds play that escort around a main compound such as CBD. If you were looking for an entourage effect definition that explains the idea simply, that image is it. One detail matters more than it seems: the word was first used in research on the body’s own endocannabinoids and only later carried over to hemp products. So the term is precise and narrow, much narrower than its use in marketing suggests.
Which Compounds Are Involved in the Entourage Effect?
The entourage effect names three groups of plant compounds: cannabinoids, terpenes and flavonoids. Together they make up the full plant profile of hemp, but they are studied to very different degrees, and what is known drops sharply from the first group to the third. A full-spectrum extract contains all three; an isolate contains none of them except the one cannabinoid it was refined to. The sections below take the groups in that order, from best to least studied.
1. Cannabinoids: CBD, THC and the Minor Cannabinoids
Cannabinoids are the best-known compound group in hemp, and in Swiss hemp extracts cannabidiol (CBD) is by far the dominant one by quantity. Alongside it, a full-spectrum extract carries minor cannabinoids in small amounts, such as cannabigerol (CBG), cannabinol (CBN) and cannabichromene (CBC); their share varies by strain and process and, where measured, is listed on the certificate of analysis. Tetrahydrocannabinol (THC) is limited by Swiss law to under 1% THC in hemp products, a legal and compositional fact rather than an argument.
That company is what people mean by the CBD entourage effect: in the entourage effect, CBD is not alone but travels with its companions in a full-spectrum extract. An isolate, by contrast, holds practically nothing but CBD, with none of the companion cannabinoids. If you want to understand what CBD is as a single compound, our guide covers it in detail. The difference between the two is one of composition, and nothing more can be read from it alone, including anything about the entourage effect of cannabinoids.
2. Terpenes: The Aromatic Compounds of the Hemp Plant
Terpenes are volatile aroma compounds formed in the trichomes of the hemp plant, and they give each strain its terpene profile, from citrusy to earthy. Frequently named examples are myrcene, limonene, pinene, linalool and beta-caryophyllene; the same compounds occur in hops, citrus peel and lavender. Because terpenes are volatile, how much of them reaches the final product depends heavily on the production process: heat, drying and storage can let part of the aroma escape before an oil is ever bottled. Two extracts from the same strain can therefore show clearly different terpene profiles. Whether terpenes play any role in the entourage effect beyond scent and flavour is a separate question, answered in the next section.
3. Flavonoids: The Least Studied Group
Flavonoids are secondary plant compounds found across the plant world, many of them known as plant pigments; in hemp, researchers have also described compounds of its own, the cannflavins. Explainer articles routinely list flavonoids as the third pillar of the entourage effect, next to cannabinoids and terpenes. The data on them, however, is much thinner than on the other two groups, and the hypothesis assumes their contribution rather than showing it. There is a practical gap too: many product analyses do not measure flavonoids at all, which we come back to in the section on labels.
How Do Terpenes Fit into the Entourage Effect?
In the entourage effect, terpenes are assumed to influence what cannabinoids do, not only how a product smells and tastes. That is the terpene version of the hypothesis, the most concrete form of the cannabis entourage effect and the one most often printed on labels. It has not been confirmed.
The idea was set out in a 2011 review that gathered lab findings on individual terpenes and turned them into an assumption still waiting to be tested. Searches for the entourage effect and terpenes almost always end up at this version, and its honest grade is easy to state: it is the part of the hypothesis with the most lab indications and the least human evidence. For which terpenes occur in the plant and how they shape a strain’s profile, see our overview of terpenes in the hemp plant. At product level, the terpenes entourage effect turns into a label promise, which gets its own section further down.
What Do Studies Show About the Entourage Effect?
Studies on the entourage effect so far show signals at a low level of evidence and very little at a high one. Most entourage effect study results cited come from cell-culture and animal models, and controlled human studies that isolate the effect are rare. Calling the effect proven skips over that gap. This is a finding, neither a dismissal nor a confirmation, and we unpack it in three steps: the original papers, the levels of evidence, and what transfers to a Swiss product.
Ben-Shabat 1998 and Russo 2011: The Papers Behind the Idea
Both original papers say something narrower than their citations suggest. Ben-Shabat and colleagues, writing in the European Journal of Pharmacology in 1998, reported in laboratory and animal experiments that fatty acid glycerol esters, inactive on their own, increased the measured activity of the body’s own endocannabinoid 2-arachidonoyl-glycerol (2-AG) [1]. They studied endocannabinoids, not plant extracts, and coined “entourage effect” for that finding.
Russo, writing in the British Journal of Pharmacology in 2011, published a review that extended the idea to phytocannabinoids and terpenoids [2]. It drew on existing lab and animal data and set out hypotheses that prompted a great deal of further research. A review summarises existing literature; it produces no new measurements and so is no confirmation. Almost every product page still cites Russo (2011) [2] as proof, which is the most common fallacy on this topic.
| Paper | Year | Publication type | Subject |
|---|---|---|---|
| Ben-Shabat et al., European Journal of Pharmacology [1] | 1998 | Laboratory and animal study | Endocannabinoid 2-AG and inactive companion esters |
| Russo, British Journal of Pharmacology [2] | 2011 | Narrative review | Phytocannabinoids and terpenoids |
Lab, Animal and Human: Three Very Different Levels of Evidence
Cell culture, animal model and controlled human study are three levels of evidence that differ in how close their result sits to a person. The higher the level, the better a finding transfers.
- Cell culture (in vitro): shows how compounds act on isolated cells or receptors. It does not show what happens in a person, because experiments often use concentrations that are practically never reached in the body.
- Animal model: shows responses in a whole organism. It does not transfer automatically to humans, because metabolism, amounts per body weight and study design differ.
- Controlled human study: the benchmark, because it works with comparison groups and random allocation. It shows only what holds under the tested conditions, and this is exactly where the data on the entourage effect is thin.
That is why the same finding can be real and still meaningless for a consumer product. When a product page quotes a figure, check which level it came from: a lab number presented as a human finding is the most common jump up this ladder.
The Gap Between Study Preparations and Swiss Products
Much of the cited research looks at preparations you cannot legally buy in Switzerland, and that is the real transferability question. Hemp products here must contain under 1% THC; above that line the Narcotics Act applies. A large part of the literature on the THC entourage effect, by contrast, works with preparations carrying far more THC or fixed cannabinoid doses, which consumer products are not standardised to. Reading about the CBD and THC entourage effect therefore usually means reading about a different composition from that of a Swiss product.
Product class adds a second break point. Swiss CBD oils are placed on the market as cosmetic or aroma products, not as medicines, so they follow different rules from a study preparation. Our article on Swiss law on CBD sets out the limits and product classes. Concentration, legal limit and product class are three points where study and shelf part ways. For Swiss products the hypothesis is not refuted, but it is far less supported than many labels suggest.
Is the Entourage Effect Real?
The entourage effect is neither a myth nor an established fact: it is a plausible but unconfirmed hypothesis. In its favour is the old argument from phytotherapy that plant compounds can behave differently in a mixture than alone. Against it, there is no evidence in humans under the conditions of a consumer product, so it is not scientifically proven.
The criticism therefore targets less the idea than its presentation as settled. Lab tests of the terpene version show why. Santiago and colleagues, writing in Cannabis and Cannabinoid Research in 2019, found in a cell-culture study that common cannabis terpenoids such as myrcene, limonene and pinene did not change the activity of THC at human CB1 and CB2 receptors [3]. That is a result at the lowest level of evidence and not a final refutation, because other routes of interaction were not tested. So is the entourage effect real? Plausible, contested and open, and we would rather say that plainly than sell it.
What Does This Mean for Full-Spectrum, Broad-Spectrum and Isolate?
Full-spectrum, broad-spectrum and isolate differ in composition, and that difference is settled. The axis they sit on is how much of the original plant profile survives processing; whether that difference does anything beyond composition is exactly the open question the entourage effect raises.
| Criterion | Full-spectrum | Broad-spectrum | Isolate |
|---|---|---|---|
| Cannabinoids contained | CBD plus minor cannabinoids such as CBG, CBN, CBC | CBD plus minor cannabinoids | Practically only CBD |
| Terpenes | Partly retained, depending on the process | Partly retained, depending on the process | Usually none |
| THC content | Traces, under 1% THC | No detectable THC | No detectable THC |
| What is missing? | Nothing from the extracted profile | The THC | Companion cannabinoids, terpenes and flavonoids |
Composition is what separates the three types, and you can read it on the certificate of analysis for each batch. We derive no ranking from it and compare the three types on nothing else. uWeed lists full-spectrum CBD oil and broad-spectrum CBD oil as separate categories, so you can compare their composition and the certificate of analysis of each product before you choose.
- What is settled is the difference in composition.
- The usual argument for full-spectrum rests on an unconfirmed hypothesis.
- Choosing between the three types is a question of composition, not of a proven advantage.
“Entourage Effect” on a Label: What a Certificate of Analysis Can Check
Phrases such as “full terpene entourage effect” or “with terpene entourage effect” appear on product labels and in shop descriptions. They describe a promise, not a measured value: no defined lab parameter corresponds to them, and “full” is not something a laboratory measures. The wording is not standardised, so you cannot check it as written.
What you can check is composition. A certificate of analysis, produced by a laboratory on behalf of the manufacturer, states CBD content, other cannabinoids and THC content for each batch.
A terpene profile is often not measured, flavonoids practically never, and no certificate states an effect. Terpenes add a second uncertainty: being volatile, only part of them survives into the oil. Our article on CO2 extraction of CBD shows how strongly the method shapes that profile. To judge a claim such as “with terpene entourage effect”, compare it with the certificate, not with the maker’s wording.
Frequently Asked Questions About the Entourage Effect
Does the Entourage Effect Only Apply to CBD?
No, the entourage effect does not only apply to CBD; the hypothesis covers the whole compound mix of the cannabis plant. Alongside CBD, CBG, CBN and CBC are regularly named as companion cannabinoids, together with terpenes and flavonoids. Ask what the entourage effect is in weed and the answer is the same: the “weed entourage effect” of forums is the entourage effect in cannabis. Phytotherapy has similar synergy assumptions for other plants, and they are no more settled there. Read more on cannabigerol (CBG) as a minor cannabinoid.
Does a Swiss Full-Spectrum Oil Contain THC?
Yes, a Swiss full-spectrum oil contains traces of THC, limited by law to under 1% THC. That is a statement about composition and the law, and for the entourage effect THC simply belongs to the profile of a full-spectrum extract. Broad-spectrum products are made so that no THC is detectable. The actual content of your oil is on the certificate of analysis for its batch, and our page on the difference between CBD and THC explains the two compounds.
Conclusion: A Hypothesis Still Waiting for Human Evidence
The entourage effect is a hypothesis first formulated in 1998 for the body’s own endocannabinoids and popularised by Russo (2011) [2] for the compounds of the hemp plant. It is plausible and not refuted, but it is not robustly supported in humans: most of the evidence comes from cell culture and animal models. For Swiss products a second gap comes on top, because the study preparations cited are composed differently from hemp products with under 1% THC. What you can actually check is therefore not an effect but a profile: cannabinoids and THC content on the certificate of analysis and, where measured, the terpenes. Naming an open question honestly is, in our view, more useful than any label promise.
Sources on the Entourage Effect
- Ben-Shabat S, Fride E, Sheskin T, Tamiri T, Rhee MH, Vogel Z et al. (1998): An entourage effect: inactive endogenous fatty acid glycerol esters enhance 2-arachidonoyl-glycerol cannabinoid activity. European Journal of Pharmacology 353(1): 23–31.
- Russo EB (2011): Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects. British Journal of Pharmacology 163(7): 1344–1364.
- Santiago M, Sachdev S, Arnold JC, McGregor IS, Connor M (2019): Absence of Entourage: Terpenoids Commonly Found in Cannabis sativa Do Not Modulate the Functional Activity of Δ9-THC at Human CB1 and CB2 Receptors. Cannabis and Cannabinoid Research 4(3): 165–176.
